J. Nicholson

A Novel Mutation of Glutamate Dehydrogenase (H262Y) in an Infant with Hyperinsulinemic Hypoglycemia and Hyperammonemia

W. Chung, R. Leibel, K. Das, 2000 .

Therapies and outcomes of congenital hyperinsulinism‐induced hypoglycaemia

I. Banerjee, K. Cosgrove, M. Dunne, 2018, Diabetic medicine : a journal of the British Diabetic Association.

Families’ Experiences of Continuous Glucose Monitoring in the Management of Congenital Hyperinsulinism: A Thematic Analysis

I. Banerjee, P. Nutter, C. Worth, 2022, Frontiers in endocrinology.

Neurodevelopmental Abnormalities in Patients with Familial Hypocalciuric Hypercalcemia Type 3.

R. Thakker, R. Padidela, F. Hannan, 2023, The Journal of pediatrics.

Vineland adaptive behavior scales to identify neurodevelopmental problems in children with Congenital Hyperinsulinism (CHI)

I. Banerjee, M. Michaelidou, L. Rigby, 2017, Orphanet Journal of Rare Diseases.

Conservatively treated Congenital Hyperinsulinism (CHI) due to K-ATP channel gene mutations: reducing severity over time

S. Ellard, N. Murphy, S. Flanagan, 2016, Orphanet Journal of Rare Diseases.

Abnormal Neurodevelopmental Outcomes are Common in Children with Transient Congenital Hyperinsulinism

P. Clayton, L. Patel, I. Banerjee, 2013, Front. Endocrinol..

Integration of nurse-led virtual reviews with growth hormone device-linked patient adherence information: a mixed methods feasibility study

C. Fullwood, I. Banerjee, H. Stokes, 2023, Frontiers in Endocrinology.

Standardised practices in the networked management of congenital hyperinsulinism: a UK national collaborative consensus

J. Houghton, S. Senniappan, I. Banerjee, 2023, Frontiers in Endocrinology.